|
Volumn 72, Issue SUPPL. 1, 2005, Pages 35-37
|
Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients
|
Author keywords
Asthma; Bronchodilation; Bronchoprotection; Dry powder inhalers; Formoterol; Hydrofluoroalkanes; Pressurized metered dose inhalers
|
Indexed keywords
CHLOROFLUOROCARBON;
FORMOTEROL;
METHACHOLINE;
NORFLURANE;
PLACEBO;
ADULT;
ARTICLE;
BRONCHODILATING ACTIVITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG TOLERABILITY;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
LUNG CLEARANCE;
LUNG FUNCTION;
MALE;
METERED DOSE INHALER;
MILD PERSISTENT ASTHMA;
MODERATE PERSISTENT ASTHMA;
POWDER INHALER;
PRIORITY JOURNAL;
ADULT;
AEROSOL PROPELLANTS;
ASTHMA;
BLOOD GLUCOSE;
BRONCHIAL PROVOCATION TESTS;
BRONCHOCONSTRICTOR AGENTS;
BRONCHODILATOR AGENTS;
CHLOROFLUOROCARBONS;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
ETHANOLAMINES;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMANS;
HYDROCARBONS, FLUORINATED;
MALE;
METERED DOSE INHALERS;
METHACHOLINE CHLORIDE;
MIDDLE AGED;
NEBULIZERS AND VAPORIZERS;
POTASSIUM;
POWDERS;
|
EID: 20944448943
PISSN: 00257931
EISSN: None
Source Type: Journal
DOI: 10.1159/000083691 Document Type: Article |
Times cited : (8)
|
References (5)
|